midostaurin — integMET

Metabolite details

Identifier: BMGQWWVMWDBQGC-IIFHNQTCSA-N
InChI Key: BMGQWWVMWDBQGC-IIFHNQTCSA-N
IUPAC name: N-[(5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-yl]-N-methylbenzamide
Preferred name: midostaurin
INN name: midostaurin
Synonym: CGP 41251
ChEBI: CHEBI:63452

R-HSA-1226099 - Signaling by FGFR in disease
R-HSA-1280215 - Cytokine Signaling in Immune system
R-HSA-1433557 - Signaling by SCF-KIT
R-HSA-162582 - Signal Transduction
R-HSA-1643685 - Disease
R-HSA-168256 - Immune System
R-HSA-1839117 - Signaling by cytosolic FGFR1 fusion mutants
R-HSA-1839124 - FGFR1 mutant receptor activation
R-HSA-5655302 - Signaling by FGFR1 in disease
R-HSA-5655332 - Signaling by FGFR3 in disease
R-HSA-5663202 - Diseases of signal transduction by growth factor receptors and second messengers
R-HSA-9006934 - Signaling by Receptor Tyrosine Kinases
R-HSA-9607240 - FLT3 Signaling
R-HSA-9669921 - KIT mutants bind TKIs
R-HSA-9669938 - Signaling by KIT in disease
R-HSA-9682385 - FLT3 signaling in disease
R-HSA-9702506 - Drug resistance of FLT3 mutants
R-HSA-9702509 - FLT3 mutants bind TKIs
R-HSA-9702600 - midostaurin-resistant FLT3 mutants